DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/12/2915/22295437/mdx411.pdf
Reference73 articles.
1. Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration;Ezzeldin;Clin Colorectal Cancer,2004
2. Scrip World Pharmaceutical News;Scrip’s Cancer Chemotherapy Report,2002
3. Safety of capecitabine: a review;Mikhail;Expert Opin Drug Saf,2010
4. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors;Lévy;J Clin Oncol,1998
5. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study;Pharmaceutics;2024-07-19
2. Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia;Internal Medicine Journal;2024-07-04
3. Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative Framework;Clinical Pharmacokinetics;2024-06
4. A novel large intragenic DPYD deletion causing dihydropyrimidine dehydrogenase deficiency: a case report;BMC Medical Genomics;2024-03-25
5. Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity;The Pharmacogenomics Journal;2024-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3